TipRanks
SRx Health Solutions (SRXH)
:SRXH
US Market
SRXH
SRx Health Solutions
RESEARCH TOOLSreports
Want to see SRXH full AI Analyst Report?

SRx Health Solutions (SRXH) Ratios

327 Followers

SRx Health Solutions Ratios

SRXH's free cash flow for Q3 2026 was C$0.27. For the 2026 fiscal year, SRXH's free cash flow was decreased by C$ and operating cash flow was C$-1.05. See a summary of the company’s cash flow.
Ratios
TTM
Sep 25Dec 24Mar 24Dec 22
Liquidity Ratios
Current Ratio
 27.55 2.29 2.10 0.38 0.67
Quick Ratio
 26.45 1.71 1.63 0.30 0.49
Cash Ratio
 15.49 0.37 0.43 0.03 0.08
Solvency Ratio
 -18.80 -5.63 >-0.01 -0.13 -0.05
Operating Cash Flow Ratio
 0.04 -2.30 -0.61 0.04 0.15
Short-Term Operating Cash Flow Coverage
 0.00 0.00 -0.12 0.08 0.60
Net Current Asset Value
C$ 62.87MC$ 131.00KC$ 7.85MC$ -45.67MC$ -19.06M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.53 2.87 0.61 0.51
Debt-to-Equity Ratio
 0.00 10.99 -0.82 -6.26 19.25
Debt-to-Capital Ratio
 0.00 0.92 -4.62 1.19 0.95
Long-Term Debt-to-Capital Ratio
 0.00 0.92 -0.01 0.00 0.91
Financial Leverage Ratio
 1.02 20.64 -0.29 -10.26 37.51
Debt Service Coverage Ratio
 -1.45 -12.71 0.01 -0.20 -0.15
Interest Coverage Ratio
 0.29 -18.16 -12.78 -2.83 -1.55
Debt to Market Cap
 0.00 0.48 11.32 1.34 9.96
Interest Debt Per Share
 0.48 14.50 28.34 3.34 26.42
Net Debt to EBITDA
 5.19 -0.40 96.44 -5.29 -30.02
Profitability Margins
Gross Profit Margin
32.49%23.35%36.77%19.85%14.36%
EBIT Margin
-46.09%-122.60%0.88%-7.36%-1.26%
EBITDA Margin
18.89%-122.13%1.25%-5.93%-0.58%
Operating Profit Margin
-4.20%-174.56%-17.06%-4.88%-1.26%
Pretax Profit Margin
26.62%-132.22%-0.45%-9.20%-2.17%
Net Profit Margin
108.05%-688.80%-0.48%-9.36%-2.64%
Continuous Operations Profit Margin
-27.54%-132.22%-0.48%-9.36%-2.64%
Net Income Per EBT
405.86%520.96%105.66%101.80%121.91%
EBT Per EBIT
-633.52%75.74%2.66%188.40%172.25%
Return on Assets (ROA)
-27.81%-535.66%-1.06%-17.27%-7.04%
Return on Equity (ROE)
-97.77%-11057.99%0.30%177.08%-264.09%
Return on Capital Employed (ROCE)
1.10%-234.74%-68.96%586.03%-9.15%
Return on Invested Capital (ROIC)
1.10%-233.73%-12.52%-16.68%-6.04%
Return on Tangible Assets
-61.83%-535.66%-1.91%-30.73%-11.02%
Earnings Yield
-219.84%-483.24%-4.98%-43.02%-166.43%
Efficiency Ratios
Receivables Turnover
 -4.37 1.66 4.52 16.85 27.41
Payables Turnover
 -19.78 2.33 0.56 3.91 5.84
Inventory Turnover
 -9.67 2.41 6.56 16.67 19.75
Fixed Asset Turnover
 -4.16K 60.50 2.79 11.18 12.59
Asset Turnover
 -0.26 0.78 2.21 1.84 2.66
Working Capital Turnover Ratio
 -0.92 -0.16 -2.15 -5.00 6.31
Cash Conversion Cycle
 -102.89 215.35 -521.16 -49.73 -30.71
Days of Sales Outstanding
 -83.61 220.37 80.79 21.66 13.32
Days of Inventory Outstanding
 -37.74 151.45 55.60 21.90 18.48
Days of Payables Outstanding
 -18.46 156.48 657.55 93.28 62.51
Operating Cycle
 -121.35 371.83 136.39 43.56 31.79
Cash Flow Ratios
Operating Cash Flow Per Share
 <0.01 -23.15 -2.70 0.23 4.80
Free Cash Flow Per Share
 -0.73 -23.15 -2.72 0.13 4.45
CapEx Per Share
 0.74 0.00 0.03 0.10 0.35
Free Cash Flow to Operating Cash Flow
 -82.76 1.00 1.01 0.55 0.93
Dividend Paid and CapEx Coverage Ratio
 0.01 0.00 -106.27 2.24 13.81
Capital Expenditure Coverage Ratio
 0.01 0.00 -106.27 2.24 13.81
Operating Cash Flow Coverage Ratio
 0.00 -1.82 -0.10 0.07 0.19
Operating Cash Flow to Sales Ratio
 >-0.01 -1.25 -0.12 0.02 0.04
Free Cash Flow Yield
-52.78%-87.43%-130.26%6.09%212.97%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.02 -0.21 -20.10 -2.32 -0.60
Price-to-Sales (P/S) Ratio
 -0.42 1.43 0.10 0.22 0.02
Price-to-Book (P/B) Ratio
 0.13 22.88 -0.06 -4.12 1.59
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.89 -1.14 -0.77 16.43 0.47
Price-to-Operating Cash Flow Ratio
 182.04 -1.14 -0.77 9.10 0.44
Price-to-Earnings Growth (PEG) Ratio
 <0.01 >-0.01 0.23 0.03 <0.01
Price-to-Fair Value
 0.13 22.88 -0.06 -4.12 1.59
Enterprise Value Multiple
 2.95 -1.56 104.15 -8.96 -32.75
Enterprise Value
 -20.85M 12.48M 45.62M 63.21M 17.66M
EV to EBITDA
 2.95 -1.56 104.15 -8.96 -32.75
EV to Sales
 0.56 1.91 1.30 0.53 0.19
EV to Free Cash Flow
 2.49 -1.53 -10.37 40.12 5.64
EV to Operating Cash Flow
 -206.41 -1.53 -10.47 22.21 5.23
Tangible Book Value Per Share
 5.52 1.16 0.77 -2.79 -16.53
Shareholders’ Equity Per Share
 12.52 1.16 -34.12 -0.51 1.32
Tax and Other Ratios
Effective Tax Rate
 -0.09 0.00 -0.06 -0.02 -0.22
Revenue Per Share
 -3.28 18.57 21.65 9.60 131.54
Net Income Per Share
 -3.54 -127.94 -0.10 -0.90 -3.48
Tax Burden
 4.06 5.21 1.06 1.02 1.22
Interest Burden
 -0.58 1.08 -0.52 1.25 1.72
Research & Development to Revenue
 0.00 0.00 <0.01 0.00 0.00
SG&A to Revenue
 0.39 1.98 0.00 0.22 0.14
Stock-Based Compensation to Revenue
 0.03 0.00 0.10 0.02 0.00
Income Quality
 0.05 0.94 0.10 -0.26 -1.38
Currency in CAD